Women's Health

>

Latest News

FDA Updates Felinzanetant Label Warnings After Report of Severe Liver Injury
FDA Updates Felinzanetant Label Warnings After Report of Severe Liver Injury

September 18th 2024

FDA heightened label warnings about hepatic injury and increased the required frequency of liver function testing after initiation of fezolinetant.

Good Cardiovascular Health Early on May Offset Genetic Risk of Hypertensive Disorders of Pregnancy / Image credit: ©Andrey Popov/AdobeStock
Good Cardiovascular Health Early on May Offset Genetic Risk of Hypertensive Disorders of Pregnancy

September 17th 2024

A False-Positive Breast Cancer Screening Result Discourages Future Mammography / image credit mammography: ©My Ocean Studio/stock.adobe.com
A False-Positive Breast Cancer Screening Result Discourages Future Mammography

September 17th 2024

Mammography facilities are now nationally required to inform patients about their breast density, which can affect cancer detection. |© Gorodenkoff/stock.adobe.com
Mammography Centers Now Mandated to Disclose Breast Density

September 11th 2024

CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose / image credit: ©New Africa/AdobeStock
CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose

September 6th 2024

Latest CME Events & Activities

8th Annual School of Nursing Oncology™

View More

Community Practice Connections™: 22nd Annual International Congress on the Future of Breast Cancer®

View More

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances...

October 10, 2024

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant ...

November 20, 2024

View More

Medical Crossfire®: Finding The Right Place for Immunotherapy and Targeted Treatments in the Management of Endometrial Cancer

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

May 3, 2025

View More

More News

© 2024 MJH Life Sciences

All rights reserved.